Trends and variations in use of antenatal corticosteroids to prevent neonatal respiratory distress syndrome: Recommendations for national and international comparative audit

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 6, 1996, Pages 534-540

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; CLINICAL TRIAL; DRUG USE; FEMALE; FETUS; HUMAN; MEDICAL AUDIT; PATIENT SELECTION; PRENATAL CARE; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME;

ADRENAL CORTEX HORMONES; BIAS (EPIDEMIOLOGY); COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MEDICAL AUDIT; ORGANIZATIONAL POLICY; PERINATAL CARE; REFERRAL AND CONSULTATION; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030025788     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09802.x     Document Type: Article

References (33)

1. Crowley P, Chalmers I, Keirse M JNC. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990; 97: 11–25.
2. Crowley P. Corticosteroids prior to preterm delivery. In Enkin MW, Keirse MJNC, Renfrew MJ, Nielson, JP, editors. Pregnancy and childbirth module [computer program]. Cochrane Database of Systematic Reviews; 1994 May. Review No.: 04391 Oxford : Cochrane Updates on Disk, Update Software, 1994: Disk Issue I.
3. Crowley P. Corticosteroids after preterm prelabour rupture of membranes. In: Enkin MW, Keirse MJNC, Renfew MJ, Nielson, JP, editors. Pregnancy and childbirth module [computer program]. Cochrane Database of Systematic Reviews; 1994 May. Review No.: 04395 Oxford : Cochrane Updates on Disk, Update Software, 1994: Disk Issue 1.
4. Collaborative Group on Antenatal Steroid Therapy. Effects of antenatal dexamethasone administration in the infant: long term follow up. J Pediatr 1984; 104: 259–267.
5. Howie RN, Liggins GC. Clinical trial of antepartum beta-methasone therapy for prevention of respiratory distress in preterm infants. In: Anderson ABM, Beard RW, Burdenell JM, Dunn, PM, editors. Preterm Labour. London : RCOG, 1977: 281–289.
6. Smolders-de, Haas H, Neuvel J, Schmand B, Treffers PE, Koppe JG, Hoeks J. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: a 10 to 12 year follow up. Pediatrics 1990; 86: 65–70.
7. Mugford M, Pierce J, Chalmers I. Cost implications of different approaches to the prevention of respiratory distress syndrome. Arch Dis Child 1991; 66: 757–764.
8. Editorial. Surfactant for babies. Lancet 1992; 340: 1387.
9. Royal College of Obstetricians and Gynaecologists Scientific Advisory Group. Corticosteroid administration and neonatal respiratory distress syndrome. London : Royal College of Obstetricians and Gynaecologists, 1992.
10. Joint Working Group of the British Association of Perinatal Medicine and the Research Unit of the Royal College of Physicians. Development of audit measures and guidelines for good practice in the management of neonatal respiratory distress syndrome. Arch Dis Child 1992; 67: 1221–1221.
11. Royal College of Obstetricians and Gynaecologists Audit Committee. Procedures suitable for audit. London : Royal College of Obstetricians and Gynaecologists, 1993.
12. National Institutes of Health Consensus Development Panel. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995; 273: 413–418.
13. Doyle LW, Permezel MJ, Kitchen W. Is there a lower limit for birthweight/gestational age and antenatal steroid therapy Aust N ZJ Obstet Gynaecol 1992; 32: 193–195.
14. SPSS for Windows Advanced Statistics 6.0 [computer program]. London : SPSS UK, 1993.
15. Khanna R, Richmond S. The OSIRIS trial. Lancet 1993; 341: 174.
16. The Osiris Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant–the judgement of OSIRIS. Lancet 1992; 340: 1363–1369.
17. Halliday H, Tarnow-Mordi WO, Corcoran JD, Patterson CC. A multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial). Arch Dis Child 1993; 69: 276–280.
18. Hack M, Horbar JD, Malloy MH, Tyson JE, Wright E, Wright L. Very low birth weight outcomes of the National Institutes of Child Health and Human Development Neonatal Network. Pediatrics 1991; 87: 587–597.
19. Wennberg JE, Blowers L, Parker R, Gittelsohn AM. Changes in tonsillectomy rates associated with feedback and review. Pediatrics 1977; 59: 821–826.
20. Editorial. Streptokinase in acute myocardial infarction. Lancet 1986; 1421–422.
21. Pentecost BL. Myocardial infarction. In: Weatherall DJ, Leding-ham JGG, Warrell, DA, editors. Oxford Textbook of Medicine. Oxford : Oxford University Press, 1987: 13: 167–182.
22. Yusuf S, Collins R, Peto E et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of Results on mortality, reinfarction and side effects from 33 randomised controlled trials. Eur Heart J 1985; 6: 556–585.
23. Gruppo Italiano per lo Studio della Streptochinasi nell'infarcto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute m%cardial infarction. Lancet 1986; 1: 397–402.
24. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither, among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349–363.
25. Yusuf S, Koon T, Woods K. Intravenous magnesium in acute myocardial infarction. An effective, safe, simple and inexpensive Intervention. Circulation 1993; 87: 2043–2046.
26. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669–685.
27. Yusuf S, Flather M. Magnesium in acute myocardial infarction. BMJ 1995; 310: 151–152.
28. Egger M, Davey, Smith G. Misleading meta-analysis. BMJ 1995; 310: 752–754.
29. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515–525.
30. Mugford M, Banfield P, O'Hanlon M. Effects of feedback of information on clinical practice: a review. BMJ 1991; 303: 398–402.
31. Domenighetti G, Luraschi P, Casabianca A et al. Effect of information campaign by the mass media on hysterectomy rates. Lancet 1988; 2: 1403–1407.
32. Williams RL, Chen PM. Controlling the rise in cesarean section rates by dissemination of information from vital records. Am J Public Health 1983; 73: 863–867.
33. Cooke RWI, Ryan S, Walkinshaw S. Steroids for babies. Lancet 1993; 341: 569.